Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity

By sjmartinez • July 10, 2024

Armstrong AW, Jaleel T, Merola JF, Gottlieb AB, Khattri S, Helt CC, Malatestinic WN, Ross SE, Ngantcha ME, de Vlam K. Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity. Dermatol Ther (Heidelb). 2024 Jul 9. doi: 10.1007/s13555-024-01221-0. Epub ahead of print. Erratum for: Dermatol Ther (Heidelb). 2024 Jun;14(6):1615-1631. doi: 10.1007/s13555-024-01188-y. PMID: 38981938.

Tags: Dermatology, Publications

Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)

Armstrong AW, Riedl E, Brunner PM, Piaserico S, Visser WI, Haustrup N, Konicek BW, Kadziola Z, Nunez M, Brnabic A, Schuster C. Identifying Predictors of[...]

Reticulated pigmentary changes and Terry’s nails in a patient with a TERT variant-associated telomere biology disorder

Noveir SD, Galamgam J, Pithadia D, Truong A, Hogeling M, Cheng CE. Reticulated pigmentary changes and Terry's nails in a patient with a TERT variant-associated[...]

Clinical consequences of age-related skin barrier dysfunction. Part I. Structural, molecular and physiologic changes with cutaneous aging

Wahhab R, Sanders M, Kokikian N, Ni C, Vandiver AR. Clinical consequences of age-related skin barrier dysfunction. Part I. Structural, molecular and physiologic changes with[...]